Vitamin C MDL Defendants Renew Call To Dismiss

Law360, New York (June 10, 2008, 12:00 AM EDT) -- Defendants in the multidistrict vitamin C antitrust litigation have again asked the judge to dismiss the case against them, saying that a supplemental memorandum filed by the plaintiffs has changed nothing.

In a motion filed Monday in the U.S. District Court for the Eastern District of New York, manufacturers Jiangsu Jiangshan Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co. Ltd., Hebei Welcome Pharmaceutical Co. Ltd. and Weisheng Pharmaceutical Co. Ltd. asked the judge to grant the motion to dismiss that they filed and argued nearly a year...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.